Copyright Reports & Markets. All rights reserved.

Global Small Molecule Drug Discovery Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Small Molecule Drug Discovery by Type
    • 1.3.1 Overview: Global Small Molecule Drug Discovery Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Small Molecule Drug Discovery Consumption Value Market Share by Type in 2025
    • 1.3.3 Target Discovery
    • 1.3.4 Target Validation
    • 1.3.5 Lead Generation
    • 1.3.6 Refinement
    • 1.3.7 Preclinical Development
    • 1.3.8 Others
  • 1.4 Global Small Molecule Drug Discovery Market by Application
    • 1.4.1 Overview: Global Small Molecule Drug Discovery Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Oncology
    • 1.4.3 Central Nervous System
    • 1.4.4 Cardiovascular
    • 1.4.5 Respiratory
    • 1.4.6 Orthopedics
    • 1.4.7 Immunology
    • 1.4.8 Rare Diseases
    • 1.4.9 Other
  • 1.5 Global Small Molecule Drug Discovery Market Size & Forecast
  • 1.6 Global Small Molecule Drug Discovery Market Size and Forecast by Region
    • 1.6.1 Global Small Molecule Drug Discovery Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Small Molecule Drug Discovery Market Size by Region, (2021-2032)
    • 1.6.3 North America Small Molecule Drug Discovery Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Small Molecule Drug Discovery Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Small Molecule Drug Discovery Market Size and Prospect (2021-2032)
    • 1.6.6 South America Small Molecule Drug Discovery Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Small Molecule Drug Discovery Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Johnson and Johnson Services, Inc.
    • 2.1.1 Johnson and Johnson Services, Inc. Details
    • 2.1.2 Johnson and Johnson Services, Inc. Major Business
    • 2.1.3 Johnson and Johnson Services, Inc. Small Molecule Drug Discovery Product and Solutions
    • 2.1.4 Johnson and Johnson Services, Inc. Small Molecule Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Johnson and Johnson Services, Inc. Recent Developments and Future Plans
  • 2.2 Teva Pharmaceutical Industries Ltd
    • 2.2.1 Teva Pharmaceutical Industries Ltd Details
    • 2.2.2 Teva Pharmaceutical Industries Ltd Major Business
    • 2.2.3 Teva Pharmaceutical Industries Ltd Small Molecule Drug Discovery Product and Solutions
    • 2.2.4 Teva Pharmaceutical Industries Ltd Small Molecule Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Teva Pharmaceutical Industries Ltd Recent Developments and Future Plans
  • 2.3 Boehringer Ingelheim International GmbH
    • 2.3.1 Boehringer Ingelheim International GmbH Details
    • 2.3.2 Boehringer Ingelheim International GmbH Major Business
    • 2.3.3 Boehringer Ingelheim International GmbH Small Molecule Drug Discovery Product and Solutions
    • 2.3.4 Boehringer Ingelheim International GmbH Small Molecule Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Boehringer Ingelheim International GmbH Recent Developments and Future Plans
  • 2.4 Allergan Plc.
    • 2.4.1 Allergan Plc. Details
    • 2.4.2 Allergan Plc. Major Business
    • 2.4.3 Allergan Plc. Small Molecule Drug Discovery Product and Solutions
    • 2.4.4 Allergan Plc. Small Molecule Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Allergan Plc. Recent Developments and Future Plans
  • 2.5 Pfizer Inc.
    • 2.5.1 Pfizer Inc. Details
    • 2.5.2 Pfizer Inc. Major Business
    • 2.5.3 Pfizer Inc. Small Molecule Drug Discovery Product and Solutions
    • 2.5.4 Pfizer Inc. Small Molecule Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Pfizer Inc. Recent Developments and Future Plans
  • 2.6 Bristol-Myers Squibb Company
    • 2.6.1 Bristol-Myers Squibb Company Details
    • 2.6.2 Bristol-Myers Squibb Company Major Business
    • 2.6.3 Bristol-Myers Squibb Company Small Molecule Drug Discovery Product and Solutions
    • 2.6.4 Bristol-Myers Squibb Company Small Molecule Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Bristol-Myers Squibb Company Recent Developments and Future Plans
  • 2.7 Merck & Co., Inc
    • 2.7.1 Merck & Co., Inc Details
    • 2.7.2 Merck & Co., Inc Major Business
    • 2.7.3 Merck & Co., Inc Small Molecule Drug Discovery Product and Solutions
    • 2.7.4 Merck & Co., Inc Small Molecule Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Merck & Co., Inc Recent Developments and Future Plans
  • 2.8 GlaxoSmithKline plc.
    • 2.8.1 GlaxoSmithKline plc. Details
    • 2.8.2 GlaxoSmithKline plc. Major Business
    • 2.8.3 GlaxoSmithKline plc. Small Molecule Drug Discovery Product and Solutions
    • 2.8.4 GlaxoSmithKline plc. Small Molecule Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 GlaxoSmithKline plc. Recent Developments and Future Plans
  • 2.9 AstraZeneca
    • 2.9.1 AstraZeneca Details
    • 2.9.2 AstraZeneca Major Business
    • 2.9.3 AstraZeneca Small Molecule Drug Discovery Product and Solutions
    • 2.9.4 AstraZeneca Small Molecule Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 AstraZeneca Recent Developments and Future Plans
  • 2.10 Gilead Sciences, Inc.
    • 2.10.1 Gilead Sciences, Inc. Details
    • 2.10.2 Gilead Sciences, Inc. Major Business
    • 2.10.3 Gilead Sciences, Inc. Small Molecule Drug Discovery Product and Solutions
    • 2.10.4 Gilead Sciences, Inc. Small Molecule Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Gilead Sciences, Inc. Recent Developments and Future Plans
  • 2.11 Novartis AG
    • 2.11.1 Novartis AG Details
    • 2.11.2 Novartis AG Major Business
    • 2.11.3 Novartis AG Small Molecule Drug Discovery Product and Solutions
    • 2.11.4 Novartis AG Small Molecule Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Novartis AG Recent Developments and Future Plans
  • 2.12 Johnson & Johnson
    • 2.12.1 Johnson & Johnson Details
    • 2.12.2 Johnson & Johnson Major Business
    • 2.12.3 Johnson & Johnson Small Molecule Drug Discovery Product and Solutions
    • 2.12.4 Johnson & Johnson Small Molecule Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Johnson & Johnson Recent Developments and Future Plans
  • 2.13 Roche Holding AG
    • 2.13.1 Roche Holding AG Details
    • 2.13.2 Roche Holding AG Major Business
    • 2.13.3 Roche Holding AG Small Molecule Drug Discovery Product and Solutions
    • 2.13.4 Roche Holding AG Small Molecule Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Roche Holding AG Recent Developments and Future Plans
  • 2.14 AstraZeneca PLC
    • 2.14.1 AstraZeneca PLC Details
    • 2.14.2 AstraZeneca PLC Major Business
    • 2.14.3 AstraZeneca PLC Small Molecule Drug Discovery Product and Solutions
    • 2.14.4 AstraZeneca PLC Small Molecule Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 AstraZeneca PLC Recent Developments and Future Plans
  • 2.15 Sanofi
    • 2.15.1 Sanofi Details
    • 2.15.2 Sanofi Major Business
    • 2.15.3 Sanofi Small Molecule Drug Discovery Product and Solutions
    • 2.15.4 Sanofi Small Molecule Drug Discovery Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Sanofi Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Small Molecule Drug Discovery Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Small Molecule Drug Discovery by Company Revenue
    • 3.2.2 Top 3 Small Molecule Drug Discovery Players Market Share in 2025
    • 3.2.3 Top 6 Small Molecule Drug Discovery Players Market Share in 2025
  • 3.3 Small Molecule Drug Discovery Market: Overall Company Footprint Analysis
    • 3.3.1 Small Molecule Drug Discovery Market: Region Footprint
    • 3.3.2 Small Molecule Drug Discovery Market: Company Product Type Footprint
    • 3.3.3 Small Molecule Drug Discovery Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Small Molecule Drug Discovery Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Small Molecule Drug Discovery Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Small Molecule Drug Discovery Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Small Molecule Drug Discovery Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Small Molecule Drug Discovery Consumption Value by Type (2021-2032)
  • 6.2 North America Small Molecule Drug Discovery Market Size by Application (2021-2032)
  • 6.3 North America Small Molecule Drug Discovery Market Size by Country
    • 6.3.1 North America Small Molecule Drug Discovery Consumption Value by Country (2021-2032)
    • 6.3.2 United States Small Molecule Drug Discovery Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Small Molecule Drug Discovery Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Small Molecule Drug Discovery Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Small Molecule Drug Discovery Consumption Value by Type (2021-2032)
  • 7.2 Europe Small Molecule Drug Discovery Consumption Value by Application (2021-2032)
  • 7.3 Europe Small Molecule Drug Discovery Market Size by Country
    • 7.3.1 Europe Small Molecule Drug Discovery Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Small Molecule Drug Discovery Market Size and Forecast (2021-2032)
    • 7.3.3 France Small Molecule Drug Discovery Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Small Molecule Drug Discovery Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Small Molecule Drug Discovery Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Small Molecule Drug Discovery Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Small Molecule Drug Discovery Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Small Molecule Drug Discovery Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Small Molecule Drug Discovery Market Size by Region
    • 8.3.1 Asia-Pacific Small Molecule Drug Discovery Consumption Value by Region (2021-2032)
    • 8.3.2 China Small Molecule Drug Discovery Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Small Molecule Drug Discovery Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Small Molecule Drug Discovery Market Size and Forecast (2021-2032)
    • 8.3.5 India Small Molecule Drug Discovery Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Small Molecule Drug Discovery Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Small Molecule Drug Discovery Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Small Molecule Drug Discovery Consumption Value by Type (2021-2032)
  • 9.2 South America Small Molecule Drug Discovery Consumption Value by Application (2021-2032)
  • 9.3 South America Small Molecule Drug Discovery Market Size by Country
    • 9.3.1 South America Small Molecule Drug Discovery Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Small Molecule Drug Discovery Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Small Molecule Drug Discovery Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Small Molecule Drug Discovery Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Small Molecule Drug Discovery Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Small Molecule Drug Discovery Market Size by Country
    • 10.3.1 Middle East & Africa Small Molecule Drug Discovery Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Small Molecule Drug Discovery Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Small Molecule Drug Discovery Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Small Molecule Drug Discovery Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Small Molecule Drug Discovery Market Drivers
  • 11.2 Small Molecule Drug Discovery Market Restraints
  • 11.3 Small Molecule Drug Discovery Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Small Molecule Drug Discovery Industry Chain
  • 12.2 Small Molecule Drug Discovery Upstream Analysis
  • 12.3 Small Molecule Drug Discovery Midstream Analysis
  • 12.4 Small Molecule Drug Discovery Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Small Molecule Drug Discovery market size was valued at US$ 13330 million in 2025 and is forecast to a readjusted size of US$ 18420 million by 2032 with a CAGR of 4.8% during review period.
    The process of small molecule drug discovery can be complex and challenging.Small-molecule drugs are organic compounds affecting molecular pathways by targeting important proteins, which have a low molecular weight, making them penetrate cells easily. Small-molecule drugs can be developed from leads derived from rational drug design or isolated from natural resources.
    The global small molecule drug discovery market refers to the pharmaceutical industry’s efforts to discover and develop new drugs based on small organic molecules. Small molecule drugs are chemical compounds with relatively low molecular weight that can interact with specific targets in the body to produce a therapeutic effect.
    The market for small molecule drug discovery is driven by the increasing demand for novel and effective drugs to treat various diseases, including cancer, cardiovascular disorders, infectious diseases, and neurological disorders. This market encompasses a wide range of activities, including target identification, hit identification and hit-to-lead optimization, lead optimization, preclinical development, and clinical trials.
    Several factors contribute to the growth of this market, such as advancements in drug screening technologies, increased understanding of disease mechanisms, and the availability of genomic and proteomic data. Additionally, the rising prevalence of chronic diseases, population aging, and the need for personalized medicine are also driving the demand for small molecule drug discovery.
    The market is highly competitive, with numerous pharmaceutical and biotechnology companies, as well as academic research institutions, involved in drug discovery efforts. These organizations invest significant resources in research and development to identify and develop innovative small molecule drugs.
    This report is a detailed and comprehensive analysis for global Small Molecule Drug Discovery market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Small Molecule Drug Discovery market size and forecasts, in consumption value ($ Million), 2021-2032
    Global Small Molecule Drug Discovery market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
    Global Small Molecule Drug Discovery market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
    Global Small Molecule Drug Discovery market shares of main players, in revenue ($ Million), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Small Molecule Drug Discovery
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Small Molecule Drug Discovery market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Johnson and Johnson Services, Inc., Teva Pharmaceutical Industries Ltd, Boehringer Ingelheim International GmbH, Allergan Plc., Pfizer Inc., Bristol-Myers Squibb Company, Merck & Co., Inc, GlaxoSmithKline plc., AstraZeneca, Gilead Sciences, Inc., etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Small Molecule Drug Discovery market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Target Discovery
    Target Validation
    Lead Generation
    Refinement
    Preclinical Development
    Others
    Market segment by Application
    Oncology
    Central Nervous System
    Cardiovascular
    Respiratory
    Orthopedics
    Immunology
    Rare Diseases
    Other
    Market segment by players, this report covers
    Johnson and Johnson Services, Inc.
    Teva Pharmaceutical Industries Ltd
    Boehringer Ingelheim International GmbH
    Allergan Plc.
    Pfizer Inc.
    Bristol-Myers Squibb Company
    Merck & Co., Inc
    GlaxoSmithKline plc.
    AstraZeneca
    Gilead Sciences, Inc.
    Novartis AG
    Johnson & Johnson
    Roche Holding AG
    AstraZeneca PLC
    Sanofi
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Small Molecule Drug Discovery product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Small Molecule Drug Discovery, with revenue, gross margin, and global market share of Small Molecule Drug Discovery from 2021 to 2026.
    Chapter 3, the Small Molecule Drug Discovery competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Small Molecule Drug Discovery market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Small Molecule Drug Discovery.
    Chapter 13, to describe Small Molecule Drug Discovery research findings and conclusion.

    Buy now